100448-06-4

Upstream product

• 100448-03-1 (+/-)-2-methyl-5-(2,3-dimethoxyphenyl)-2-azabicyclo<3.3.1>non-3-ene 
• 100430-70-4 (+/-)-1-methyl-4-(2,3-dimethoxyphenyl)-4-(3-propenyl)-1,4,5,6-tetrahydropyridine 
• 82359-62-4 1-methyl-4-hydroxy-4-(2,3-dimethoxyphenyl)piperidine 
• 82359-63-5 4-(2,3-Dimethoxyphenyl)-1,2,3,6-tetrahydro-1-methyl-pyridine 
• 91-16-7 1,2-dimethoxybenzene 
• 1445-73-4 1-Methyl-4-piperidone 
• 100448-04-2 (+/-)-2-methyl-4-bromo-5-(2,3-dimethoxyphenyl)-2-azabicyclo<3.3.1>non-3-ene 

Relevant academic research and scientific papers

Probes for Narcotic Receptor Mediated Phenomena. 9. Synthesis of (+/-)-(3α,6aα,11aβ)-1,3,4,5,6,11a-Hexahydro-2-methyl-2H-3,6a-methanobenzofuroazocin-10-ol, an Oxide-Bridged 5-(m-Hydroxyphenyl)morphan

The synthesis of racemic (3α,6aα,11aβ)-1,3,4,5,6,11a-hexahydro-2-methyl-2H-3,6a-methanobenzofuroazocin-10-ol (2d) is described.The route used acid-catalyzed ring closure of enamine 5 to yield the unsaturated phenylmorphan 6.Conversion of 6 to oxide